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The Finnish National Prevention and Treatment Programme for Chronic Bronchitis and
COPD, launched in 1998, has, to date, been running for 6 years (2003).
The goals of this action programme were to reduce the incidence of COPD and the number
of moderate and severe cases of the disease, and to reduce both the number of days of
hospitalisation and treatment costs.
A prevalent implementation of over 250 information and training events started.
Health centres and pharmacies appointed a person in charge of COPD patients.
In order to improve the cooperation between primary and specialised care, two thirds of
hospital districts created local COPD treatment chains.
The early diagnosis of COPD by spirometric examination was activated during the
programme. Number of health centres with available spirometric services increased
to 95%.
Before the start of the programme, approximately 5–9% of the adult population had COPD.
During the whole programme, the proportion of male and female smokers decreased from
30% to 26% and from 20% to 19%, respectively. The total number of hospitalisation periods
and days due to COPD decreased by 15% and 18%, respectively. Both the number of
pensioners and daily sickness days due to COPD also decreased by 18%. Registered COPD
induced deaths remained at their previous levels during the monitoring period, i.e. aroundElsevier Ltd. All rights reserved.
4542120; fax: +358 9 45421210.
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(5) Improvement in guided self-c
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A. Pietinalho et al.14201000 deaths out of 5.2 millions annually. The measures recommended by the programme
have been widely introduced but they need to be still more effective.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is marked
public health problem. In 1998, approximately 400,000 Finns
out of a total population of 5.2 million had chronic
bronchitis, and half of them symptomatic pulmonary
obstruction.1 The total annual treatment costs for COPD
are around 0.8 billion EUR. The national programme of
Chronic Bronchitis and Chronic Obstructive Pulmonary
Disease was designed by The Finnish Lung Health Association
(Filha) between 1996 and 1997 in cooperation with the
Ministry of Social Affairs and Health and with the help of a
working group of experts. It was subsequently published on
behalf of the Ministry of Social Affairs and Health in 1998.2–4
This action programme aims to reduce the incidence of
COPD and the number of moderate and severe cases of the
disease as well as to reduce the number of days of
hospitalisation and the treatment costs (Table 1).
Before or outside the COPD Programme, the Finnish
Tobacco Act first prohibited advertising as early as 1976 and
in 1994 smoking in public places and at the workplace as
well as the sale of tobacco products to minors.
Filha has been the main organisation coordinating the
programme.
For that purpose, Filha set up a working group of experts
to gather and assess data on the work carried out in Finland
in connection with the implementation of the COPD
Programme, on the resources available and on the treat-
ment given during the course of the programme in Finland.Actions taken
Filha has been providing on-going support for the training
and implementation of the programme jointly with Uni-r the COPD Programme.2–4
ent of chronic bronchitis and CO
ronic bronchitis
suffering from chronic bronchi
work and functional capacity of
atients with moderate to severe
e in number of days spent by CO
patient
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d outdoor air pollutants and im
risk factors and treatment of th
and active treatment, among sm
are
bilitation, planned individually
esearchversity Hospitals and Health Care Centres (Table 2). Initially,
information on the programme was widely distributed to
health care professionals in all hospital districts between
1997 and 1999. Nationwide training of occupational health
care workers followed this, organised in cooperation with
regional occupational health care institutions in 2000.
Seminar topics included COPD as a disease, its diagnosis
and treatment, smoking cessation, and regional treatment
chains.
Between 2001 and 2003 a multidisciplinary, interactive
training project for all health centres (156 of 271) was
carried out. Also, representatives of local pharmacies were
invited. Training material was based on the COPD Pro-
gramme and on the evidence-based medicine (EBM) guide-
lines of the Finnish Medical Society Duodecim.2,5 Events for
education and practical training for spirometry were ar-
ranged in the whole country.
Also the hospital districts organised local training for
their primary health care workers. At the order of the
Ministry of Social Affairs and Health and with its
support, Filha, in 2002 and 2003, carried out measures in
connection with the implementation of the EBM Guideline
on Smoking, Nicotine Dependency and Smoking Cessation.6
Also, Pulmonary Association Heli trained counsellors for
smoking cessation groups and has been running of a national
free-of-charge ‘‘quit line’’, called Stumppi since 2003.
In addition, around 10 hospitals had by 2003 signed
up to Finland’s Smoke-free Hospital Network, based on
the EU network project titled Health Promoting Hospitals.
Published national guidelines for measurement and
assessment of spirometry and PEF (peak expiratory flow)7
were effectively distributed to laboratories and units
performing these examinations thus improving the quality
of spirometry especially for early detection of bronchial
obstruction.PD
tis as possible
patients with COPD
COPD
PD patients in hospital
of chronic bronchitis and COPD
provement of quality of air indoors
e disease in key groups
okers in particular
and mainly implemented as an element in treatment
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Table 2 COPD-related training for health care professionals in 1997–2003, organised by Filha and Pulmonary Association
Heli.
Project/event Time (year(s)) Number of
events
Number of health
care professionals
participating
Training organised by Filha
First National COPD Day 1997 1 300
Seminars for individual hospital districts 1997–1999 27 2000
Seminars organised with regional occupational health
institutions
2000 7 600
Training at individual health centres 2001–2003 156 3500
COPD Programme presented at the physicians’ event
‘‘Doctors Days’’
1998–1999 3 200
Project to improve the quality of spirometric examinations 2001–2003 25 800
Other training 1997–2003 20 1400
Training organised by Pulmonary Association Heli
Information meetings for health care professionals 1998–2003 21 1400
Total 260 10,200
Chronic bronchitis and chronic obstructive pulmonary disease 1421During the implementation of the programme, hospitals
and health care centres were encouraged to build up
treatment chains and to improve resources, particularly in
primary health care.
The overall aim of the COPD Programme was broadly to
encourage a healthy lifestyle among COPD patients.
Given the high number of COPD patients and long
distances in the north of Finland, Ranua health centre in
Lapland put special emphasis to COPD patients in 1998 and
1999, to diagnose and treat COPD and particularly to treat
exacerbations and manage oxygen therapy at home.
The Pulmonary Association Heli is the most important
patient organisation supporting COPD patients. During the
first 6 years of the COPD Programme, Heli ran three projects
supported by the Finnish Slot Machine Association that have
been useful for the treatment of COPD patients: (1) the
‘‘Oxygen Network’’ project, (2) a family-centred rehabilita-
tion project for respiratory patients, and (3) a compact
guide, ‘‘’Good Practice in the Rehabilitation of Respiratory
Patients’’, especially for occupational health services and
health centres. The number of rehabilitation courses
organised by Association Heli for COPD patients as well as
the number of participants increased seven times between
1997 and 2003. Outpatient rehabilitation courses were
organised on three occasions from 1997 to 1999.Outcomes
Improvements in passive exposure to tobacco
smoke, smoking habits and treatment of smoking
As a result of the Tobacco Act, involuntary exposure to
tobacco smoke at the workplace has been declining. The
proportion of non-smokers who are not exposed to tobacco
smoke during their working day increased from 21% to 71%between 1994 and 1998.8 The amendments of the Act in
1999 resulted in a gradual ban of smoking in restaurants.
The implementation of the COPD Programme and EBM
Guideline on Smoking Cessation2,6 improved considerably
the attitude of health personal to smoking cessation and it
was accepted as a part of the treatment of COPD. At first
time, tobacco contact nurses were established in primary
health care and hospitals.
Smoking among Finns slightly decreased during the
programme. Thirty per cent of adult men and 20% of women
were smokers in 1997. In 2003, the proportion of male and
female smokers had fallen to 26% and 19%, respectively.9 In
the late 1980s, almost 40% of 16-year-old boys smoked, but
according to the recent Study on Adolescent Health 2003,
conducted by STAKES (the National Research and Develop-
ment Centre for Welfare and Health), 23% of boys aged
between 14 and 18 smoked; among girls, the proportion of
smokers was 26%. Studies conducted in 1987 and again 1997
found that the proportion of smokers among pregnant
mothers had remained the same, 15%.10Still high prevalence of COPD in Finland
Before the COPD Programme, approximately 400,000 people
(10% of adults) in Finland were calculated to have chronic
bronchitis, with 200,000 of them (5% of adults) having
symptomatic COPD.1 In 1995, the FinEsS project, an
extensive on-going epidemiological study on asthma, COPD
and pulmonary symptoms, was launched in three countries:
Finland, Estonia and Sweden. Based on those studies,11 5.4%
of Finns aged between 21 and 70 had COPD (British Thoracic
Society (BTS) criteria). When the GOLD criteria (Global
Initiative for Chronic Obstructive Lung Disease) were
applied, the percentage was 9.4%. So, the real number of
COPD patients is at least as high as the old estimations
showed.
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A. Pietinalho et al.1422Lesser need of hospitalisation and lover mortality
Hospitalisation due to COPD was decreased: 18% fewer
hospitalisation days and 15% fewer hospitalisation periods
occurred in 2003 compared to that in 1997,12 (www.stakes.fi).
The biggest change was observed among the elderly. These
decreases from 1997 to 2003 were highly significant in all age
groups for men ðpo0:001Þ, but for women only in the age
group 65–74.
According to the statistics of the Finnish Population
Register in 1998, 1147 COPD-related deaths were recorded
and in 2003 the number was 1041. Since 1998, mortality has
decreased annually by 2.8%, at best.Improvement of treatment chains and resources
Filha conducted two surveys among the chief physicians of
30 pulmonary units, one in 2000 and the other in 2003
(Pietinalho A, personal communication). The response rate
to both surveys was 97%. In 2000, half of chief physicians in
pulmonary units and three years later, 70% reported the
existence of a regional programme. Twelve of the regional
treatment chain programmes are published on the Internet:
www.Terveysportti.fi.
Health centre resources for the treatment and diagnosis
of COPD patients were assessed during the three-year
training project for individual health centres ðn ¼ 156Þ
carried out by Filha (2001–2003) (Kontula E, personal
communication). Ninety-two health centres (59%) replied
(Table 3). Correspondingly, the resources of the Asthma
Programme13 and for the treatment of asthma were assessed
in a study using structured telephone interviews with 271
health centres14 (Table 3).
In addition to primary and specialist health care, there
were around 600 pharmacies in Finland where asthma
counsellors were appointed. Now, they work also as
counsellors for COPD patients and for supporting smoking
cessation.
A follow-up quality assessment on spirometric examina-
tions was conducted by a postal survey in 1999. The
opportunities for diagnosing COPD, i.e. for performing
spirometric examinations, were relative good in health
centres. During nine years, the quality of spirometric
examinations was clearly improved, although some pro-
blems still existed. The frequency of spirometer calibration
and the use of recommended Finnish reference valuesTable 3 Health centre resources for the treatment of asthma
Question/information sought Treatment
accordanc
Programm
Is familiar with the programme/the EBM guideline
There is a physician in charge 83
There is a nurse in charge 94
The health centre has a spirometry device 95
The health centre gives advice on smoking cessation 53
EBM ¼ evidence based medicine.(1982)15 had markedly increased but questions regarding the
quality of a single graph and the repeatability of graphs
were problematic (Table 4).16
Treatments of exacerbations in primary health care
as well
In 2003, as the result of the training project centre the
treatment of COPD exacerbations had become more
effective in Ranua health centre and the use of specialist
health care for COPD patients had decreased significantly.
As one of the treatment options for COPD patients, home
nursing units have been set up in different parts of Finland in
recent years. According to an experiment at the hospital of
Porvoo, one half of the COPD exacerbations requiring
hospital care could be managed at home.17
Activated use of respiratory devices
The supply and use of respiratory devices is regulated by the
Act on Health Care Devices and Equipment.18 One evaluation
of the use of the respiratory devices was made just before
the programme in 199719 and four were made during the
period 1998–2003. These showed that the number of
patients using respiratory devices increased constantly and
was statistically significant increased until the year 2003:
users of oxygen therapy from 1810 to 2198 ðpo0:001Þ and
CPAP devices from 3741 to 10,510 ðpo0:001Þ.
Rehabilitation more ordinary
The statistics of the Finnish Social Insurance Institution (SII)
and the employment pension system show that the number
of COPD-related sickness pensions granted decreased
between 1996 and 2002 by 14% (from 2252 to 1944) and
the number of COPD-related daily sickness allowance
periods paid by the SII decreased by 18% (from 1509
to 1235).
Increased research activity
One of the measures of the COPD Programme was to
encourage scientific research. A number of studies have
been made. The previously mentioned FinEsS project is
expected to bring further long-awaited clarification to the
epidemiology of COPD.11,20–24 In addition to this, ongoingand COPD.
resources in Treatment resources in
e with the Asthma accordance with the COPD Programme
e14 (%) (Kontula E, personal communication) (%)
78/85
30
34
82
63
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Table 4 Quality index for spirometric examinations16 (www.filha.fi).
Criterion
number
Criterion (main points) Maximum
score
1 Time reserved for the examination 6
2 Calibration frequency 6
3 Written instructions for calibration 2
4 Use of a nose clip 4
5 Asking about medication and drawing conclusions from the response 10
6 Criteria for approving an exhalation 8
7 Criteria for the repeatability of graphs 12
8 Reference value praxis 8
9 Following recommendations on spirometric examinations 4
10 Printing each graphs 6
11 Giving an end result graph of the result 4
12 Parameters printed 15
13 Giving a report on the spirometry 5
14 Participating in training or in courses on spirometry (in relation to the number of staff) 10
Total 100
Chronic bronchitis and chronic obstructive pulmonary disease 1423COPD-related research is being carried out in Finland in
cooperation with the Department of Respiratory Diseases at
HUCH, the Skin and Allergy Hospital and Oulu University
Hospital. There is also collaboration with the University of
Southampton and the Denver Jewish Medical Research
Center. The purpose of the above studies is to develop
new non-invasive examination methods to assess the
inflammation and tissue damage observed in connection
with smoking and COPD focusing on sputum and exhaled
air.25–27 The studies also assess the lung’s defence mechan-
isms by examining biopsy samples taken from smokers
and COPD patients, and look for factors that might indicate
the development or progress of the disease.28–30 The
National Public Health Institute annually monitors the
health habits of adults (aged 16–64) on the basis of
10,000-person population samples. Smoking habits of the
population were assessed as part of this.9,10 Separate
studies have been carried out to investigate smoking and
exposure to tobacco smoke among employees8 and smoking
habits among health care professionals. At the same time,
attempts have been made to assess the attitudes of health
care staff to smoking cessation. Smoking among health care
professionals has clearly reduced. The significance of
passive exposure to tobacco smoke has also been studied
in Finland, and it has proved for the first time that passive
exposure to tobacco smoke increases the lifetime risk of
asthma.31Discussion
The single most important factor causing COPD is smoking
and the main goal of the programme is to stop people
smoking. A study published by Lundba¨ck’s Swedish research
group indicates that up to half of smokers may develop
COPD, whereas the previous estimates were 15–20%.32
The state and municipalities play an important role in
preventing young people from starting smoking. The Finnish
Tobacco Act aims to reduce passive exposure to tobaccosmoke in particular. The Act and the resulting discussion
have been exceptionally effective in reducing smoking
among adults but less so among adolescents. The informa-
tion given during the implementation of the COPD Pro-
gramme may also have influenced smoking habits among
adults. At the start of the programme, attitude surveys
conducted during training events for health care profes-
sionals still showed that smoking cessation was not
considered the task of health care professionals but was
thought to be the responsibility of NGOs. This situation has
already changed (Table 3). In addition, the practical
implementation of the EBM Guideline for Smoking Cessation5
began at the end of 2002. Information campaigns and
increased access to smoking cessation services may also
have helped to reduce smoking among adults.
COPD is often diagnosed in older patients who have a long
history of smoking. The Finnish population is ageing, which
further increases the incidence of COPD. Even if we were
able to influence the extent of smoking immediately, the
associated decrease in COPD would be slow. The monitoring
period for the programme is still too short to observe any
convincing changes in the COPD prevalence.
In the mid-1990s, it was expected that the number of
COPD-related days of hospitalisation and days of hospital
treatment would double by 2020.33 One of the aims of the
COPD action programme is to achieve an overall 25%
reduction in hospitalisation (Table 1). The programme can
explain the reduced number of hospitalisation days partly.
Already before the programme the structure of the hospital
networks changed. For example reduced number of hospital
beds and increased emphasis on outpatient care were having
an influence on the figures. On the other hand, the
decreasing needs for hospital care,12 as well as the
reduction in the number of sickness leave periods and
retirements may indicate that patients are coping better
despite the disease.
The long-acting bronchodilators and a new long-acting
anticholinergic medication33 that have become available to
COPD patients during the programme may improve the
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A. Pietinalho et al.1424patients’ ability to cope. Also, the stuff of primary health
care is now more aware of COPD and its treatment.
During the programme, the number of patients with
severe COPD and those who use oxygen therapy has
continued to rise. This is mainly due to the fact that the
criteria for treatment have been clarified and that the
availability of treatment has improved.
One of the aims of the action programme is to reduce
severe disease and the number of COPD-related deaths.
However, since 1998, mortality has been decreasing
annually by 2.8% at best. On the other hand, the mortality
figures are evidently underestimations despite the 6-years’
period of the COPD Programme: a cardiac event, for
instance, is often registered as the cause of death of a
COPD patient.
Diagnostic resources and quality of the COPD seems to be
improved during the programme;14,16 the patients’ access to
spirometry has enhanced and the technical quality and
interpretation abilities have improved, partly by the aid of
effectively launched Finnish Guidelines for recording and
assessment of spirometry.7 More frequent detection of
irreversible small airways obstruction in asymptomatic
smokers may have improved the motivation to stop smoking.
The systematic practical implementation of the COPD
Programme2 and the Asthma Programme13 preceding it
seems to have created opportunities for effective COPD
diagnosis and treatment in all health care sectors. It is
crucially important that education about COPD and the
development of health care structures are continued in
order to ensure early diagnosis, early treatment, smoking
cessation, appropriate patient monitoring and early rehabi-
litation.
Since the COPD Programme started in 1998, a few
criticisms have been directed at it. In the literature,34
national COPD treatment guidelines including the Finnish
treatment programme2 have been criticised for not being
based on scientific evidence. However, the National COPD
Programme2 was based on the available literature and the
experiences and knowledge of a wide group of experts. The
programme also gave recommendations for the organisation
of the COPD work. Further more, the Finnish EBM guideline
for COPD5,35 was published only a year after the publication
of the COPD Programme. The content of the guideline could
therefore be quickly added to the tools for the practical
implementation of the programme. There was, conse-
quently, confirmed scientific evidence for the message.
To date, the COPD Programme has been successful in
reaching its targets partly. Nevertheless, some changes in
the development recommended by the programme may be
due to changes in health care resources and organisations
and developments in medication.Acknowledgements
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